Recursion Pharmaceuticals

ISIN US75629V1044

 | 

WKN A3CM1C

Marktkapitalisatie (in EUR)
1,490 m
Land
United States
Sector
Healthcare
Dividendrendement
0.00%
 

Overzicht

Beschrijving

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
Toon meer Toon minder
Healthcare Healthcare Services Miscellaneous Healthcare United States

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 1,490 m
WPA, EUR -1.31
KBV 1.5
K/W -
Dividendrendement 0.00%

Income statement (2025)

Omzet, EUR 66 m
Netto-inkomen, EUR -572 m
Winstmarge -863.35%

What ETF is Recursion Pharmaceuticals in?

There are 4 ETFs which contain Recursion Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Recursion Pharmaceuticals is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weging Investeringsfocus Fondsgrootte (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.13%
Equity
United States
Health Care
Biotech
45
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
506
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.00%
Equity
North America
Social/Environmental
25
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.02%
Equity
United States
Small Cap
201
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.